PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports.

European Journal of Nuclear Medicine and Molecular Imaging
M J M UijenJ Nagarajah

Abstract

In the past decade, a growing body of literature has reported promising results for prostate-specific membrane antigen (PSMA)-targeted radionuclide imaging and therapy in prostate cancer. First clinical studies evaluating the efficacy of [177Lu]Lu-PSMA radioligand therapy (PSMA-RLT) demonstrated favorable results in prostate cancer patients. [177Lu]Lu-PSMA is generally well tolerated due to its limited side effects. While PSMA is highly overexpressed in prostate cancer cells, varying degrees of PSMA expression have been reported in other malignancies as well, particularly in the tumor-associated neovasculature. Hence, it is anticipated that PSMA-RLT could be explored for other solid cancers. Here, we describe the current knowledge of PSMA expression in other solid cancers and define a perspective towards broader clinical implementation of PSMA-RLT. This review focuses specifically on salivary gland cancer, glioblastoma, thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, lung cancer, and breast cancer. An overview of the (pre)clinical data on PSMA immunohistochemistry and PSMA PET/CT imaging is provided and summarized. Furthermore, the first clinical reports of non-prostate cancer patients treated with PSMA-RLT are ...Continue Reading

References

Feb 13, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·M L Janssen-Heijnen, J W Coebergh
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Sandra DemariaSilvia C Formenti
Mar 24, 2006·World Journal of Surgery·Yoshihisa KinoshitaGabriel P Haas
Jul 1, 2006·Molecular and Cellular Biology·Rebecca E ConwayLinda H Shapiro
Mar 18, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Hikmat A Al-AhmadieVictor E Reuter
Oct 29, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Houda BoukherisGraça M Dores
Oct 29, 2011·Archives of Pathology & Laboratory Medicine·A Gabriella WernickePhilip H Gutin
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
May 30, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott T TagawaDavid M Nanus
Aug 24, 2013·Frontiers in Oncology·Darren BradyKevin M Prise
Oct 18, 2013·The New England Journal of Medicine·Sunit Das, Philip A Marsden
Nov 7, 2013·JAMA : the Journal of the American Medical Association·Antonio Omuro, Lisa M DeAngelis
Dec 7, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Alla Gabriella WernickeSandra J Shin
Apr 24, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Emre DemirciBedii Kanmaz
Oct 7, 2014·International Journal of Cancer. Journal International Du Cancer·Carlo La VecchiaEva Negri
Oct 9, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Johannes SchwenckChristian la Fougère
Apr 29, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Frederik A VerburgFlorian F Behrendt
May 2, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Mike SathekgeThomas Ebenhan
Jul 15, 2015·Applied Immunohistochemistry & Molecular Morphology : AIMM·Maria C TsourlakisSarah Minner
Aug 20, 2015·Annals of Nuclear Medicine·Steven P RoweMohamad E Allaf
Nov 21, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Thomas PykaMatthias Eiber
Dec 2, 2015·Seminars in Interventional Radiology·Christopher Molvar, Robert Lewandowski
Feb 2, 2016·Clinical Nuclear Medicine·Deepa ShettyAmanda Stevanovic
Feb 10, 2016·Clinical Nuclear Medicine·Ingo EinspielerMatthias Eiber
Feb 26, 2016·Clinical Nuclear Medicine·Sameer Kamalakar TaywadeChandrasekhar Bal
Mar 12, 2016·Journal of Nuclear Medicine Technology·Sait SagerKerim Sönmezoglu
Mar 18, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Clemens KratochwilUwe Haberkorn
Jun 1, 2016·Lancet·Maria E CabanillasCosimo Durante
Jun 23, 2016·Nuclear Medicine Communications·Emre DemirciLevent Kabasakal
Jul 9, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Clemens KratochwilAlfred Morgenstern
Sep 9, 2016·Clinical Nuclear Medicine·Sangeeta TanejaAmarnath Jena
Oct 22, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kambiz RahbarBernd Joachim Krause
Nov 9, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Mike SathekgeChristophe Van de Wiele
Nov 16, 2016·Clinical Nuclear Medicine·Arun SasikumarSuresh Nair

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.